Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4–24 years in Turkey M. Cevik, U. Beyazova, A.L. Aral, A. Duyan.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

Vaccines for the elderly

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

S. Haessler, A. Paez, M. Rothberg, T. Higgins

New and old risk-factors for Toxoplasma gondii infection: prospective cross-sectional study among military personnel in the Czech Republic P. Kolbekova,

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects K. Ekelund, P. Skinhøj, J. Madsen, H.B.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

A serosurvey of Orientia tsutsugamushi from patients with scrub typhus

Virological tools to diagnose and monitor hepatitis C virus infection

R. Cantón Clinical Microbiology and Infection

Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus P.-R. Hsueh, L.-M. Huang, P.-J.

Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4–24 years in Turkey M. Cevik, U. Beyazova, A.L. Aral, A. Duyan.

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Non-antibiotic strategies for sepsis

Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR T. Kallonen, J.

Prevalence of Toscana virus antibodies in residents of Croatia

Surveillance of Legionnaires’ disease in Austria

In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species Jacques Dubois, Claude St-Pierre Clinical.

Vector control: a cornerstone in the malaria elimination campaign

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels B. Sarov, L. Novack, N.

R. Karakus, K. Caglar, C. Aybay Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

Z. Wang, Z. Cui, Y. Li, T. Hou, X. Liu, Y. Xi, Y. Liu, H. Li, Q. He

H. Völzke, K. M. Kloker, A. Kramer, L. Guertler, M. Dören, S. E

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

Previously unknown species of Aspergillus

Laboratory diagnosis of Clostridium difficile disease

A case of pleurisy associated with antibodies to Rickettsia conorii

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

The practice of travel medicine in Europe

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection R. Nir-Paz, A. Michael-Gayego, M. Ron, C.

Reducing antibiotic use in influenza: challenges and rewards

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

Vaccines for the elderly

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

C.P. Kelly Clinical Microbiology and Infection

Survival of rhinoviruses on human fingers

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

D. Baud, C. Kebbi, J.-P. Külling, G. Greub

Are we losing the fight against malaria one more time?

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

L. Bichaud, R. P. Piarroux, A. Izri, L. Ninove, C. Mary, X

S.-H. Kung, S.-F. Wang, C.-W. Huang, C.-C. Hsu, H.-F. Liu, J.-Y. Yang

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4–24 years in Turkey M. Cevik, U. Beyazova, A.L. Aral, A. Duyan Camurdan, S. Ozkan, F. Sahin, C. Aybay Clinical Microbiology and Infection Volume 14, Issue 4, Pages 388-390 (April 2008) DOI: 10.1111/j.1469-0691.2007.01926.x Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Occurrence of Bordetella pertussis (mixture of pertussis toxin (PT) and filamentous haemagglutinin (FHA)) IgG antibodies according to age group. Clinical Microbiology and Infection 2008 14, 388-390DOI: (10.1111/j.1469-0691.2007.01926.x) Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 The frequency of anti-pertussis IgG titres (mixture of pertussis toxin (PT) and filamentous haemagglutinin (FHA)) in different age groups. Clinical Microbiology and Infection 2008 14, 388-390DOI: (10.1111/j.1469-0691.2007.01926.x) Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions